Tag: hepatitis B
-
Goats and Soda Explains: CDC Cuts Back on Childhood Vaccines
Overview: A landmark shift in the childhood vaccine schedule In a move that surprised doctors and parents alike, the Centers for Disease Control and Prevention (CDC) announced an unprecedented reduction in the number of vaccines recommended for all children. The decision, disclosed on Monday, simplifies the vaccine schedule by eliminating several doses and consolidating recommendations.…
-
Goats and Soda: CDC Trims Childhood Vaccine Recommendations
New CDC Guidance Signals a Shift in Childhood Immunization The Centers for Disease Control and Prevention recently announced an unprecedented adjustment to the recommended vaccine schedule for children. In a move that caught many families and pediatricians by surprise, the agency streamlined the list of vaccines it advises all children receive. The change is drawing…
-
RFK Jr. Doubts Vaccines as CDC Cuts Child Vaccination Schedule
Overview: A Policy Shift Sparks Debate A recent move by the Centers for Disease Control and Prevention (CDC) to reduce the number of vaccines recommended for all children has stirred both political and public health conversations. Among those weighing in is Robert F. Kennedy Jr., a prominent, though controversial, figure in the vaccine dialogue. His…
-
Backed Vaccination Study Begins in Guinea: Delaying Hepatitis B for Newborns
Overview of the Trial A new, government-funded clinical study began this week in Guinea-Bissau, focused on the timing of hepatitis B vaccination for newborns. The project, supported by funding from the United States Centers for Disease Control and Prevention (CDC), aims to delay the initial hepatitis B vaccine dose for some infants so researchers can…
-
Backed Vaccination Study Begins In Guinea
Overview A new, government-supported study has kicked off in Guinea-Bissau to investigate the optimal timing for administering hepatitis B vaccines to newborns. Funded by a U.S. government agency and coordinated with local health authorities, the trial could delay vaccination for up to about 7,000 newborns while researchers monitor outcomes. The study aims to determine whether…
-
Guinea-Bissau Hepatitis B Vaccination Timing Study Begins
Overview of the Guinea-Bissau Vaccination Timing Study A US government-funded study has begun in Guinea-Bissau to examine whether delaying the first hepatitis B vaccination for newborns could influence health outcomes. The trial, which involves up to 7,000 newborns, seeks to compare different vaccination timing strategies and assess any differences in infection rates, immune response, and…
-
Silent threat: Kenya confronts rising hepatitis cases amid HIV decline
The shifting tide of infectious diseases in Kenya Kenya is grappling with a silent public health threat: hepatitis infections are on the rise even as HIV rates trend downward. This shift underscores the country’s evolving disease landscape and the need for targeted prevention, testing, and treatment strategies that address hepatitis B and hepatitis C—two infections…
-
Silent threat in Kenya: hepatitis cases rise as HIV declines
Overview: a shifting public health landscape in Kenya On World Hepatitis Day, Kenya faces a sobering paradox: while HIV infections have edged downward in recent years, hepatitis infections are showing worrying signs of growth. Public health officials warn that this silent threat could undermine gains in other sexually transmitted disease (STD) control unless accelerated action…
-
Hepatitis B Vaccine Contract Sparks Ethics Concerns in Guinea-Bissau
Overview of the Contract The Trump administration has reportedly awarded a $1.6 million, no-bid contract to a Danish university to study hepatitis B vaccinations in newborns in Africa. Reports indicate the project focuses on administering Hepatitis B vaccines to infants in Guinea-Bissau, a West African country, with researchers hoping to gather data on safety, efficacy,…
-
Trump Admin Awards Hepatitis B Vaccine Contract to Europeans in Guinea-Bissau
Overview of the Controversial Award The Trump administration has awarded a $1.6 million, no-bid contract tied to a hepatitis B vaccination project involving newborns in Africa. The grant went to a Danish university, raising questions about procurement practices, ethics, and the role of foreign researchers in public health initiatives abroad. While supporters say the project…